Geneesmiddelen in ATC-groep L — Antineoplastische en immunomodulerende middelen

Overzicht van geneesmiddelen in ATC-klasse L (Antineoplastische en immunomodulerende middelen) en hun beschikbaarheid in Belgische apotheken.

1857 geneesmiddelen

• Verzenios 150 mg — abemaciclib
• Verzenios 50 mg — abemaciclib
• Verzenios 50 mg — abemaciclib
• Vesanoid 10 mg — tretinoïne
• Vidaza 25 mg/ml — azacitidine
• Vinblastine Teva 1 mg/ml — vinblastine
• Vincrisin 1 mg/ml — vincristine
• Vincrisin 1 mg/ml — vincristine
• Vinorelbin Eugia 10 mg/ml
• Vinorelbin Eugia 10 mg/ml — vinorelbine
• Vinorelbine Accord Healthcare 10 mg/ml
• Vinorelbine Sandoz 10 mg/ml
• Vinorelbine Sandoz 10 mg/ml — vinorelbine
• Vitrakvi 100 mg — larotrectinib
• Vitrakvi 100 mg — larotrectinib
• Vitrakvi 20 mg/ml — larotrectinib
• Vitrakvi 20 mg/ml — larotrectinib
• Vitrakvi 25 mg — larotrectinib
• Votrient 200 mg — pazopanib
• Votrient 400 mg — pazopanib
• Votubia 10 mg — everolimus
• Votubia 2 mg — everolimus
• Votubia 2.5 mg — everolimus
• Votubia 3 mg
• Votubia 5 mg — everolimus
• Votubia 5 mg — everolimus
• Vyvgart 1000 mg — efgartigimod alfa
• Vyvgart 20 mg/ml — efgartigimod alfa
• Vyxeos Liposomal 2.2 mg/ml - 5 mg/ml — daunorubicine + cytarabine
• Wezenla 130 mg — ustekinumab
• Wezenla 45 mg — ustekinumab
• Wezenla 45 mg — ustekinumab
• Wezenla 45 mg — ustekinumab
• Wezenla 90 mg — ustekinumab
• Wezenla 90 mg — ustekinumab
• Xagrid 0.5 mg — anagrelide
• Xalkori 200 mg — crizotinib
• Xalkori 250 mg — crizotinib
• Xeljanz 1 mg/ml — tofacitinib
• Xeljanz 10 mg — tofacitinib
• Xeljanz 10 mg — tofacitinib
• Xeljanz 11 mg — tofacitinib
• Xeljanz 11 mg — tofacitinib
• Xeljanz 5 mg — tofacitinib
• Xeljanz 5 mg — tofacitinib
• Xeljanz 5 mg — tofacitinib
• Xeljanz 5 mg — tofacitinib
• Xeljanz 5 mg — tofacitinib
• Xeloda 150 mg — capecitabine
• Xeloda 500 mg — capecitabine
• Xospata 40 mg — gilteritinib
• Xtandi 40 mg — enzalutamide
• Xtandi 40 mg
• Yervoy 5 mg/ml — ipilimumab
• Yervoy 5 mg/ml — ipilimumab
• Yervoy 5 mg/ml — ipilimumab
• Yervoy 5 mg/ml — ipilimumab
• Yescarta 0,4–2 x 10*8 cells — axicabtagene ciloleucel
• Yesintek 130 mg — ustekinumab
• Yesintek 45 mg — ustekinumab